Bangkok Dusit Medical Services (BDMS) plans to further develop its specialised care for cancer patients by joining hands with Japan's National Cancer Center, in a move to upgrade Thailand's cancer research and care to the Asia-Pacific level.
The study will analyze blood samples of up to 96 patients using Illumina's TruSight Oncology 500 circulating tumor DNA comprehensive genomic profiling assay.